Importantly, the median OS was decreased for patients with HNSCC demonstrating high YY1 mRNA expression, and patients with a combined high expression of YY1 and CP2 mRNA showed a worse survival. The gene discussed is TFCP2; the disease is head and neck squamous cell carcinoma.